Cadila Healthcare receives USFDA clearance for Moraiya facility

17 Feb 2017 Evaluate

Cadila Healthcare has received US Food and Drug Administration (USFDA) clearance for its Gujarat plant after an inspection. The USFDA inspected company’s Moraiya facility from February 6, 2017 to February 15, 2017. At the end of the inspection, no observation (483) has been issued.

Earlier, USFDA had issued a warning letter to the Cadila’s facility at Moraiya in Gujarat for breach of good manufacturing practices.

Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.



Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×